Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2007; 13(40): 5343-5350
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5343
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5343
Table 1 Patient characteristics
| IFN group(n = 42) | Non-IFN group(n = 42) | P | |
| Median age in years (range) | 621 (45-69) | 631 (40-69) | NS |
| Gender (male/female) | 36/6 | 29/13 | NS |
| Alb (g/dL) | 3.91 | 3.91 | NS |
| PLT (× 10000/μL) | 121 | 11.51 | NS |
| ICG R-15 (%) | 171 | 181 | NS |
| CH or Child A/B | 35/7 | 35/7 | NS |
| Size of main tumor (mm) | 201 (10-50) | 151 (10-50) | NS |
| AFP (ng/mL) | 261 | 31.41 | NS |
| No. of HCC (single/two or three) | 30/12 | 36/6 | NS |
| Stage (I/II or III) | 14/28 | 23/19 | NS |
| Treatment of HCC (medical/surgical) | 18/24 | 20/22 | NS |
- Citation: Jeong SC, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K. Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. World J Gastroenterol 2007; 13(40): 5343-5350
- URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5343.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i40.5343